1. Introduction {#s0005}
===============

From its initial report on two female patients in 1979 by J.O. Susac, Susac syndrome (SuS) or SICRET (small infarctions of cochlear, retinal and encephalic tissue) has persisted as an elusive entity. To date the available evidence for its treatment is based on case reports and case series. The largest systematic review described only 304 reported cases since the 1970s [@bb0005]. Here we presented the first reported case to our knowledge in Mexican population and the unusual presentation in a pregnant patient.

2. Clinical case {#s0010}
================

A 34-year-old Hispanic woman was brought to the ER in our hospital for apathy and behavioral changes. She had no prior neurological or systemic disease, no exposure to toxic or vascular risk factors, and had suffered a self-limiting (3-days duration) episode of incapacitating vertigo 6 months prior and an episode of right ear tinnitus (2 days of duration) 2 months before hospitalization without receiving any medical care.

Upon arrival at the ER, her husband described a one-month history of behavioral changes with apathy, progressive abulia, visuospatial disorientation, and gait deterioration. Initial exploration revealed a patient with auto-activation apathy, monotonous and dysprosodic speech and bilateral corticospinal involvement with hyperreflexia and Babinski\'s sign but no weakness.

The initial lab test shows no significance except by a positive qualitative hCG. The patient was unable to answer for any G/O history and her husband was also oblivious about it. An MRI was obtained and showed hyperintense periventricular white matter lesions in T2 and FLAIR sequences also involving bilateral basal ganglia and with predominant affection of the corpus callosum, in addition to infratentorial cerebellar lesions. Lesional restriction of diffusion but no contrast enhancement was observed. T1 weighted images showed hypointense lesions in the same topography ([Fig. 1](#f0005){ref-type="fig"}). Due to prominent pericallosal lesions with clinical findings of medial frontal syndrome and bilateral corticospinal involvement of monophasic subacute evolution, primary vs secondary demyelinating disease was suspected. A lumbar puncture was performed resulting and CSF values showed proteins of 77 mg/dl, glucose of 52 mg/dl (serum glucose of 89 mg/dl), and no cells. Anti-AQP4 antibodies and oligoclonal bands were absent in CSF. A comprehensive workup for viral encephalitis and atypical infectious-disease result negative and cultures for fungi and bacteria. Also given the impossibility to further image studies as a complete CT and PET, a workup for paraneoplastic neurologic antibodies was obtained that was also negative Complete rheumatologic workup was negative except for 1: 2560 antinuclear antibodies in a speckled staining fine pattern without any systemic clinical correlate. Obstetric evaluation showed a normal development 15 weeks GA fetus.Fig. 1MRI FLAIR sequence. Part 1 and 2 Pretreatment images shows hyperintense lesions with predominantly pericallosal involvement in the subependymal striatons and the *snowball* lesions. Part 3 and 4 shows IgIV post treatment changes with almost complete disappearance of the previous lesions.Fig. 1

Upon admission, 5 pulses of methylprednisolone were administered without obvious clinical improvement. Immunomodulatory treatment was escalated to intravenous immunoglobulin (IVIg) at 0.4 g/kg/day for 5 days. After treatment with IVIg, neuropsychiatric symptoms of medial frontal syndrome remitted, and the patient could cooperate for further study. Ophthalmologic assessment revealed retinal vasculitis corroborated by fluorangiography (FA) ([Supplementary Fig. 1](#ec0005){ref-type="supplementary-material"}). Audiometric testing showed bilateral sensorineural hearing loss. A new MRI showed prior lesions to be smaller or absent, and the patient showed clinical improvement confirmed by neuropsychological testing. Once the diagnosis of SuS was established. The husband decided not to continue further with the pregnancy and a therapeutic abortion was performed, the patient was discharged for further treatment with oral steroids and CCF.

3. Discussion and conclusion {#s0015}
============================

Here we discuss an atypical patient with the unusual diagnosis of Susac syndrome in a Mexican woman who was also in the first trimester of pregnancy. The anatomical basis of the clinical diagnosis as a subacute and evolving frontal syndrome in a young woman guide or workup to focus in autoimmune disorders, demyelinating disorders and structural lesions. The MRI allows to focus on the overview of predominantly callosal disease.

Differential diagnosis of corpus callosum lesions includes demyelinating, non-demyelinating inflammatory lesions, and transient splenial lesions. Demyelinating lesions include MS, neuromyelitis optica and ADEM, all of which were discarded in this patient based on the respective criteria for each one. Non-demyelinating inflammatory lesions include SuS and CNS vasculitis [@bb0010]. It is particularly important to differentiate SuS from MS. In SuS, lesions of the corpus callosum are typically centrally located, while the lesions in MS and ADEM involve the undersurface at the septal interface, in MS, these lesions are often extended around the venules of the brain, resulting in a finger-like appearance ("Dawson fingers"), while lesions appear circular in SuS. Typically, these callosal lesions involve the central fibers and spare the periphery [@bb0015] MRI reveals widespread abnormalities of the corpus callosum, manifested as small central holes, particularly in the splenium. Linear defects of the corpus callosum can also be detected, the so-called "spokes", representing microinfarctions of obliquely radiating axons [@bb0020]. The localization of the lesions is probably explained by the angioarchitecture of the corpus callosum. The inflammation and occlusion of the small precapillary arterioles with a diameter under 100 μm result in infarction of the central portion, but not the undersurface of the corpus callosum [@bb0020]. Subsequent documented involvement of retinal vasculitis and vestibulocochlear damage established the diagnosis in our patient.

SuS is currently considered a vasculitis with predominantly endothelial affection of autoimmune origin probably mediated by endothelial cell antibodies (AECA), with subsequent response by complement with C4d deposits, "mummification" phenomena, and endothelial necrosis [@bb0025]. Nevertheless, a study showed that in fact only 30% of patients with definite SuS have AECA, suggesting that AECA represent a secondary phenomenon in an etiologically heterogeneous syndrome, with a pathogenesis still far from fully understood [@bb0030]. Respecting the other autoantibodies and considering the high titers of ANA in our patients we found that antinuclear autoantibodies have been described in patients with SuS, but do not occur more often than in healthy controls [@bb0030].

Diagnosis of SuS is predominantly clinical and based on the evidence of the originally described triad with encephalic, retinal and vestibulocochlear affection. The clinical features include encephalopathy that is characterized by headache that may be migrainous or oppressive. Headache often occurs up to six months before the onset of the other symptoms. It is probably due to an affection of the leptomeningeal vessels. The other symptoms of encephalopathy have a stroke-like or subacute onset, with neuropsychological deficits, bladder disturbance, long tract signs, focal neurological signs, seizures, and often disturbance of consciousness [@bb0005]. The hearing loss can be a dramatic and severely disabilitating feature of Susac syndrome. It often occurs overnight and may affect both ears. A loss of the low or middle frequencies is typical, but loss of high frequencies can also occur. The severe hearing loss is often accompanied by vertigo and a roaring tinnitus. The hearing loss is caused by occlusion of the cochlear precapillary arterioles and those of the semicircular canal. Hearing loss is often irreversible and may require cochlear implants or hearing devices for a whole life [@bb0035]. Typical findings in patients with SuS include branch retinal artery occlusions (BRAO) detectable on retinal fluorescein angiography, the occlusions may affect the periphery and may not lead to clinical symptoms, but they can also affect the larger branches resulting in visual field deficits. Many patients complain about blurred vision or photopsia [@bb0035]. MRI, retinal fluorescein angiography, and audiometry are considered crucial tests to enable diagnosis.

In 2016, specific diagnostic criteria based on a cohort of 32 patients was proposed: Definitive SuS requires involvement of these 3 systems [@bb0040]. Being a rare disease, the clinical course and prognosis is largely unknown. Based on empirical stratification [@bb0045] the course can be monocyclic, polycyclic and chronic--continuous with a cutoff parameter of 2 years separating the monocyclic course from the other forms.

Many treatment approaches for SuS have been described in case reports and series, but rigorous analysis of these therapies is limited by inconsistent and often incomplete reports. In the acute period, treatment with steroids, IVIg, plasma exchange, and even rituximab has been reported with predominantly successful response [@bb0050]. Antithrombotic agents and nimodipine have also been used, aiming to maintain blood flow and prevent vasospasm [@bb0035]. Optimal chronic management and duration of treatment is unknown, yet the decision to withdraw treatment must incorporate surveillance brain MRI and FA findings in addition to clinical symptoms and signs.

We have managed to find 7 cases previously reported in the literature in English and in Spanish of cases that have started with Susac syndrome during pregnancy [@bb0055], [@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085] ([Table 1](#t0005){ref-type="table"}). Unfortunately, the behavior of the disease is heterogeneous. Dr. Aubert-Cohen et al. have also managed to report the behavior of the disease before and after pregnancy in 4 patients. Obviously, the low frequency of the disease does not allow obtaining any statistically significant result. But we hope that this article will serve as a foundation for future research.Table 1Comparison of data of the different reported cases of Susac syndrome with onset in pregnancy.Table 1Cases12345678Published byGordon1991^8^McFayden1987^9^Hua2014^10^Ionnides2013^11^Engelholm2013^12^Antulov2014^13^Feresiadou2014^14^Our caseOriginUSCanadaUSAustraliaGermanyCroatiaSwedenMexicoAge2831252832213534Gestational age at onset (weeks)28No specified141332353715Previous medical historyNoneNoneNoneEpilepsy from a perinatal ischaemic eventNoneNoneApparent similar clinical picture at 12 yo, treated with steroidsNoneSystem of onsetEyeEyeAuditoryNeurologicNeurologicNeurologicAuditoryAuditoryNeurologic symptomsUnilateral weakness, dysarthria and apathyAtaxia and dysarthriaAmnestic syndrome, Gait disorder, Bilateral severe weaknessBilateral severe weakness and dysarthriaEncephalopathic syndrome and Unilateral weaknessBilateral severe weakness and progressive cognitive affectionNoneCognitive affection (frontal medial syndrome) and bilateral weaknessOphthalmologic symptomsVisual field deficitVisual field deficitLoss of visual acuityLoss of visual acuityVisual field deficitNoneLoss of visual acuity and visual field deficitLoss of visual acuityAuditory symptomsBilateral neurosensorial hearing lossBilateral tinnitus and neurosensorial hearing lossTinnutusRight neurosensorial hearing lossNeurosensorial hearing lossLeft neurosensorial hearing lossTinnitus and left neurosensorial hearing lossTinnitus and bilateral neurosensorial hearing lossAdditional or atypical affectionNoneNoneCervical cord involvementNoneLivedo racemosaNoneNoneNoneTime until fully triad (months)12641.5Not completedNot completed6  MRI findingsDeep grey matterNoNot doneYesYesYesYesNoYesWhite matterCallosal and periventricularNot doneCallosal and periventricular lesionsCallosalCallosal and periventricular lesionsCallosal and periventricular lesionsNoCallosalPosterior fossa involvementNoNot doneYesNo, but also reported meningeal enhancementYesYesNoNoGadolinium enhancementNo reportedNot doneYesNo reportedYesNo reportedNoYes  CSF findingsProteins mg/dlNo reported25295200018001009No performed77Cells (Mono)No reported069No reportedNo reportedNo performed0  TreatmentInitial treatmentHeparinNoneIVMP × 5IVMP × 3IVMP × 5IGIV × 5IVMP × 5IVMP × 5ResponsePartialPartialNo responsePartialComplete responsePartialNo response2nd line treatmentNoneNoneOral prednisonePLEX and IVIgOral prednisoneNoneNoneIgIVChronic treatmentWarfarinOral prednisoneMMFMMFMMF + MTXAZAOral prednisoneCCFResponseAlmost complete recoveryPartial remissionPartial remissionNo responseAlmost complete recoveryAlmost complete recoveryAlmost complete recoveryPartial remission  PrognosisFollow up (years)0.241.53.510.230.5SequelsVisual deficitMild hearing lossCognitive deficit with visuospatial and word recallNo specifiedMild cognitive deficitSubtle weaknessMild left hearing lossCognitive deficitCourse of diseaseMonocyclicMonocyclicChronic continuousProbably MonocyclicProbably MonocyclicMonocyclicProbably MonocyclicFinal pregnancy stateHealthy productHealthy productHealthy productTherapeutic abortion at 15 weeks GAHealthy productHealthy productHealthy productTherapeutic abortion at 17 weeks GA

The following are the supplementary data related to this article.Supplementary Fig. 1Retinal Fluorangiography reveals predominantly acute and branch arterial occlusions with secondary retinal infarctions.Supplementary Fig. 1
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